Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis

[1]  M. Rossol,et al.  "Pain and fatigue in adult patients with rheumatoid arthritis : association with demographic factors, disease related factors, body awareness, emotional and psychosocial factors" , 2012 .

[2]  P. Tak,et al.  Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. , 2012, Journal of immunological methods.

[3]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[4]  A. Mantovani,et al.  Cancer‐promoting tumor‐associated macrophages: New vistas and open questions , 2011, European journal of immunology.

[5]  A. Chawla,et al.  Alternative macrophage activation and metabolism. , 2011, Annual review of pathology.

[6]  C. Peterson,et al.  Adipose tissue macrophages in insulin resistant subjects are 1 associated with collagen VI, fibrosis and demonstrate 2 alternative activation , 2010 .

[7]  P. Tak,et al.  Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials , 2010, Annals of the rheumatic diseases.

[8]  J. Casanova,et al.  Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors , 2010, Immunity.

[9]  P. Gimotty,et al.  Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. , 2010, The Journal of clinical investigation.

[10]  H. Wilson.  Macrophages heterogeneity in atherosclerosis – implications for therapy , 2010, Journal of cellular and molecular medicine.

[11]  Steven J. M. Jones,et al.  Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. , 2010, The New England journal of medicine.

[12]  J. Joyce,et al.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. , 2010, Genes & development.

[13]  Olivier Levillain,et al.  Macrophage Plasticity in Experimental Atherosclerosis , 2010, PloS one.

[14]  J. Pablos,et al.  Synovial immunopathological changes associated with successful abatacept therapy in a case of severe refractory psoriatic arthritis , 2009, Annals of the rheumatic diseases.

[15]  E. Pamer,et al.  Distinct Responses of Human Monocyte Subsets to Aspergillus fumigatus Conidia1 , 2009, The Journal of Immunology.

[16]  M. Hebbar,et al.  Interferon‐γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor‐associated macrophages , 2009, International journal of cancer.

[17]  P. Tak,et al.  The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. , 2009, Arthritis and rheumatism.

[18]  R. Lutter,et al.  Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. , 2009, Arthritis and rheumatism.

[19]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[20]  P. Comoglio,et al.  Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages , 2008, The Journal of experimental medicine.

[21]  F. Geissmann,et al.  Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T‐cell responses , 2008, Immunology and cell biology.

[22]  R. Inman,et al.  Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulation. , 2008, Arthritis and rheumatism.

[23]  Stephen W. Waldo,et al.  Heterogeneity of human macrophages in culture and in atherosclerotic plaques. , 2008, The American journal of pathology.

[24]  F. Karpe,et al.  Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages , 2008, Circulation.

[25]  C. Wijbrandts,et al.  Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker. , 2007, Arthritis and rheumatism.

[26]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[27]  G. Zlabinger,et al.  Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production , 2007, International Journal of Obesity.

[28]  E Crivellato,et al.  Macrophages in rheumatoid arthritis. , 2007, Histology and histopathology.

[29]  L. Ziegler‐Heitbrock,et al.  The CD14+ CD16+ blood monocytes: their role in infection and inflammation , 2007, Journal of leukocyte biology.

[30]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[31]  A. Boots,et al.  Synovial inflammation does not change in the absence of effective treatment: implications for the use of synovial histopathology as biomarker in early phase clinical trials in rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[32]  D. Baeten,et al.  Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies. , 2005, Arthritis and rheumatism.

[33]  D. Foell,et al.  Differential expression and response to anti‐TNFα treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis , 2005, The Journal of pathology.

[34]  D. Foell,et al.  Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis , 2005, Arthritis research & therapy.

[35]  D. Baeten,et al.  Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy , 2005, Arthritis research & therapy.

[36]  A. Zwinderman,et al.  Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis , 2004, Annals of the rheumatic diseases.

[37]  A. Zwinderman,et al.  Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[38]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[39]  D. Baeten,et al.  Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy , 2004, Annals of the rheumatic diseases.

[40]  S. Moestrup,et al.  Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis. , 2004, Arthritis and rheumatism.

[41]  P. Tak,et al.  Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints , 2003, Annals of the rheumatic diseases.

[42]  L. Joosten,et al.  Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. , 2003, Arthritis and rheumatism.

[43]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[44]  Andrew C. Li,et al.  The macrophage foam cell as a target for therapeutic intervention , 2002, Nature Medicine.

[45]  H. Makino,et al.  CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[46]  M. Fishbein,et al.  Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes , 2002, Circulation research.

[47]  T. Espevik,et al.  The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF1 , 2002, The Journal of Immunology.

[48]  A. Bell,et al.  The CD14+ CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus , 2002, Rheumatology International.

[49]  Martine De Vos,et al.  Cartilage-derived morphogenetic protein-1 and -2 are endogenously expressed and stimulate proteoglycan synthesis in healthy and osteoarthritic human articular chondrocytes , 2001, Arthritis Research.

[50]  B. Bresnihan,et al.  The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. , 2000, Arthritis and rheumatism.

[51]  G. Burmester,et al.  Macrophages in rheumatoid arthritis , 2000, Arthritis research.

[52]  T. Langmann,et al.  Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.

[53]  J. Domínguez,et al.  The porcine 2A10 antigen is homologous to human CD163 and related to macrophage differentiation. , 1999, Journal of immunology.

[54]  N. Van Rooijen,et al.  Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis , 1998, Annals of the rheumatic diseases.

[55]  F. Breedveld,et al.  Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. , 1997, Arthritis and rheumatism.

[56]  M. Ernst,et al.  Differential expression and function of CD80 (B7‐1) and CD86 (B7‐2) on human peripheral blood monocytes , 1996, Immunology.

[57]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[58]  M. Dougados,et al.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. , 1991, Arthritis and rheumatism.

[59]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[60]  P. Tak,et al.  Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis. , 2012, Arthritis and rheumatism.

[61]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[62]  M. Vos,et al.  Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. , 2001, Arthritis and rheumatism.

[63]  A. Balsa,et al.  Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue. , 1996, British journal of rheumatology.